Using models of human small cell lung carcinoma, the investigators found that a higher proportion of CD8+ cells, rather than CD4+ cells, were expressing Nrp1, and that SEMA3a-NRP1 interactions inhibit CD8+ cell functions. Here, NRP1 is linked to small cell lung carcinoma.